Live Breaking News & Updates on Accelerating Phase

(3)
NEW YORK and LONDON, Jan. 13, 2021 (GLOBE NEWSWIRE) Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ( Tiziana or the Company ), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, announces the appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer.
Dr Graham is a medicines development expert and Infectious Diseases Epidemiologist with global Biotech and Pharma R&D experience in Phase I-IV therapeutics as well as
in-vivo & in-vitro diagnostics, across many modalities. He has in depth Global Development Expertise (e.g. Virology, Respiratory, Dermatology, Allergy, & Rheumatology) in early & late stage Clinical Development and in Medical Affairs, with a strong track record for Developing and Accelerating Phase I-IV programs. Multiple IND s, NDA/BLA filings and/or defense and multiple successful launches. ....

United States , University Of Adelaide , South Australia , United Kingdom , City Of , Kunwar Shailubhai , Robert Emmet , Neil Graham , Gabriele Cerrone , Murray Jo Turner , John Hopkins University , Public Health , Trimeris Inc , Global Development Expertise , Affairs At Glaxo Welcome , Clinical Development , Regeneron Pharmaceuticals Inc , Tiziana Life Sciences Plc Adr Aktie , Tiziana Life Sciences , School Of Hygiene , Strategic Program Direction , Optiva Securities Limited Broker , Redchip Companies Inc , Cairn Financial Advisers , Life Sciences , Chief Medical ,